Abstract
La declaración de pandemia por parte de la Organización Mundial de la Salud (OMS) a causa del virus SARS-CoV-2 es un problema de salud pública sin precedentes para la humanidad con gran impacto en la calidad de vida, morbimortalidad y sostenibilidad para todos los sistemas de salud a nivel global. Las personas con diálisis de mantenimiento se consideran una población de alto riesgo de infección por SARS CoV2, en virtud de las implicaciones que suponen la multimorbilidad y las condiciones asociadas al envejecimiento. La periodicidad de la diálisis, la necesidad de viajar con frecuencia a las unidades de diálisis, el contacto comunitario, la agrupación inevitable de pacientes durante los turnos de diálisis, además del impacto humano, social y económico de la pandemia aumentan aún más el riesgo de transmisión viral. En Colombia se reportan más de 3.000 casos de enfermedad renal en niños y cerca de 40 mil personas en estadio 5 o con requerimiento de terapia remplazo renal, de las cuales, aproximadamente 56% corresponden a adultos mayores de 60 años con dos o más comorbilidades (1). Por lo tanto, la Asociación Colombiana de Nefrología e Hipertensión Arterial y la Asociación de Nefrología Pediátrica conscientes de la responsabilidad académica y científica y alineados con la propuesta del consenso nacional (2), generamos a través del Comité de Gestión de Conocimiento una convocatoria multidisciplinaria de expertos, con el fin de desarrollar mediante un consenso multidisciplinario de expertos, recomendaciones informadas en evidencia para la prevención, diagnóstico y manejo de infección por SARS CoV2/COVID-19, generando un estándar colombiano que permita orientar la toma de decisiones clínicas y estratégicas en el cuidado centrado en las personas con enfermedad renal crónica, aportando con rigurosidad y pragmatismo en los aspectos de impacto en la gestión de la población de alto riesgo, los cuales no están cubiertos en profundidad en las recomendaciones nacionales.
References
2. Instituto de Evaluación Tecnológica en Salud, Asociación colombiana de Infectología. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID-19. Rev Colomb infectología. 2020;24:47.
3. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis [Internet]. 2020;20(5):533–4. Available from: http://dx.doi.org/10.1016/S1473-3099(20)30120-1
4. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [Internet]. 2020;395(10229):1054–62. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30566-3
5. Cuenta de Alto Costo (CAC). Situación de la enfermedad Renal Crónica, Hipertensión arterial y Diabetes Mellitus en Colombia 2018. 2018;
6. Angel-Korman A, Brosh T, Glick K, Leiba A. [COVID-19, THE KIDNEY AND HYPERTENSION]. Vol. 159, Harefuah. Israel; 2020. p. 231–4.
7. Tang B, Li S, Xiong Y, Tian M, Yu J, Xu L, et al. Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient. Kidney Med [Internet]. 2020;1–5. Available from: https://doi.org/10.1016/j.xkme.2020.03.001
8. Sociedad Latinoamericana de Nefrología e Hipertensión. Recomendaciones para el manejo de pacientes portadores de enfermedad renal frente a la epidemia de coronavirus (COVID-19). 2020;(15).
9. Joanna Briggs Institute. The Joanna Briggs Institute Scientific Writer Handbook. 2018;29. Available from: http://joannabriggs-webdev.org/assets/docs/scientificWriters/JBI Scientific Writer Handbook_July 2018.pdf
10. Burgner A, Ikizler TA, Dwyer JP. COVID-19 and the Inpatient Dialysis Unit: Managing Resources During Contingency Planning Pre-Crisis. Clin J Am Soc Nephrol. 2020;15(4).
11. Perico L, Benigni A, Remuzzi G. Should covid-19 concern nephrologists? why and to what extent? The emerging impasse of angiotensin blockade. Nephron [Internet]. 2020; Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L631369382
12. Alberici F, Del Barba E, Manenti C, Econimo L, Valerio F, Pola A, et al. [Managing patients in dialysis and with kidney transplant infected with Covid-19]. G Ital Nefrol. 2020 Apr;37(2).
13. Haberal M. COVID-19 UPDATE. Vol. 18, Experimental and clinical transplantation?: official journal of the Middle East Society for Organ Transplantation. Turkey; 2020. p. 139–40.
14. Scarpioni R, Manini A, Valsania T, De Amicis S, Albertazzi V, Melfa L, et al. Covid-19 and its impact on nephropathic patients: the experience at Ospedale “Guglielmo da Saliceto” in Piacenza. G Ital Nefrol [Internet]. 2020;37(2). Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L631503189
15. Manganaro M, Baldovino S, Besso L, Biancone L, Boero R, Borzumati M, et al. First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy. J Nephrol. 2020;40(0123456789):2–4.
16. Izzedine H, Jhaveri KD, Perazella MA. COVID-19 therapeutic options for patients with kidney disease. Kidney Int [Internet]. 2020; Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L2005613343
17. Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol [Internet]. 2020 Mar;2019(0123456789):9–10. Available from: https://doi.org/10.1007/s11255-020-02451-9
18. Rubin R. Finding Ways to Reduce Coronavirus Exposure During Dialysis. JAMA. 2020;1–3.
19. Palevsky PM, Radhakrishnan J, Townsend RR, Bakris GL, Forman JP. END-STAGE KIDNEY DISEASE. 2020;2019:1–18.
20. Weiner DE, Watnick SG. Hemodialysis and COVID-19: An Achilles’ Heel in the Pandemic Health Care Response in the United States. Kidney Med [Internet]. 2020;XX:1–4. Available from: https://doi.org/10.1016/j.xkme.2020.03.004
21. Kong L-LI, Yip ILP, Mok W-SG, Chan SYM, Tang M-KC, Wong SWY, et al. Infection Control Precautions for SARS Outbreak in a Tertiary Renal Center in Hong Kong. Dial Transplant [Internet]. 2004;33(4):188–93. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L38470775
22. NICE. COVID-19 rapid guideline: dialysis service delivery (NG160). NICE Guidel 2020 [Internet]. 2020;(March). Available from: https://www.nice.org.uk/guidance/ng160
23. Wilkie M, Davies S. Peritoneal Dialysis in the time of COVID-19. Perit Dial Int. 2020;896860820921657.
24. Pino M del, Macía M, Sequera P. Documento técnico Recomendaciones para el manejo , prevención y control de COVID-19 en Unidades de Diálisis. 2020;1–13.
25. Policlinico Milan. Preventive measures in haemodialysis centre of Policlinico Milan during COVID-19 Epidemic. :7–8.
26. Christensen L, Rasmussen CS, Benfield T, Franc JM. A Randomized Trial of Instructor-Led Training Versus Video Lesson in Training Health Care Providers in Proper Donning and Doffing of Personal Protective Equipment. Disaster Med Public Health Prep. 2020;
27. Lee J-J, Lin C-Y, Chiu Y-W, Hwang S-J. Take proactive measures for the pandemic COVID-19 infection in the dialysis facilities. J Formos Med Assoc [Internet]. 2020; Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L2005548218
28. Nathan N. Waste Not, Want Not: The Re-Usability of N95 Masks. Anesth Analg. 2020;1–3.
29. Francisco ALM De, Canga JLP. Coronavirus y Riñón ASPECTOS EPIDEMIOLOGICOS DEL COVID-19. 2020;24. Available from: file:///C:/Users/Zona Informatica/Downloads/nefrologia-dia-287 (1).pdf
30. Kliger AS, Silberzweig J. Mitigating Risk of COVID-19 in Dialysis Facilities. Clin J Am Soc Nephrol [Internet]. 2020; Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L631300155
31. Meijers B, Messa P, Ronco C. Safeguarding the Maintenance Hemodialysis Patient Population during the Coronavirus Disease 19 Pandemic. Blood Purif [Internet]. 2020; Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L631577659
32. Dong J. Estrategias para el manejo de la pandemia COVID 19 en pacientes en diálisis peritoneal. International Society for Peritoneal Dialysis (ISPD). 2020;
33. Basile C, Combe C, Pizzarelli F, Covic A, Davenport A, Kanbay M, et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant [Internet]. 2020; Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L631289370
34. Massachusetts General Hospital. Guia de tratamiento COVID-19 Massachussett General Hospital. 2020;1–14.
35. Arenas MD, Villar J, González C, Cao H, Collado S, Crespo M, et al. Manejo de la epidemia por coronavirus SARS-CoV-2 (COVID-19) en unidades de hemodiálisis. Nefrología [Internet]. 2020;2(x x):1–7. Available from: https://doi.org/10.1016/j.nefro.2020.04.001
36. American Society of Nephrology. Recommendations on the care of hospitalized patients with covid-19 and kidney failure requiring renal replacement therapy. 2020;1–5.
37. de Sequera Ortiz P, Quiroga Gili B, de Arriba de la Fuente G, Macia Heras M, Salgueira Lazo M, Del Pino Y Pino MD. Protocol against coronavirus diseases in patients on renal replacement therapy: Dialysis and kidney transplant. Nefrologia. 2020 Apr;
38. Yanyan W, Hongyu L, Xiangbo X, Xingshun G, KexinQi Z. ?????????????????????????. Chinese J Hepatol. 2020;
39. Ferrey AJ, Choi G, Hanna RM, Chang Y, Tantisattamo E, Ivaturi K, et al. A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease. Am J Nephrol [Internet]. 2020; Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L631577742
40. Fu D, Yang B, Xu J, Mao Z, Zhou C, Xue C, et al. COVID-19 Infection in a Patient with End-Stage Kidney Disease. Nephron [Internet]. 2020 Mar;1–3. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L631474044
41. Rombolà G, Heidempergher M, Pedrini L, Farina M, Aucella F, Messa P, et al. Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy. J Nephrol [Internet]. 2020;33(2):193–6. Available from: https://doi.org/10.1007/s40620-020-00727-y
42. Wang R, Liao C, He H, Hu C, Wei Z, Hong Z, et al. COVID-19 in Hemodialysis Patients: A Report of 5 Cases. Am J Kidney Dis [Internet]. 2020;XX(December 2019):2019–21. Available from: https://doi.org/10.1053/j.ajkd.2020.03.009
43. Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol [Internet]. 2020;127(March):104364. Available from: https://doi.org/10.1016/j.jcv.2020.104364
44. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 2020 Mar;368:m1091.
45. Ikizler TA, Kliger AS. Minimizing the risk of COVID-19 among patients on dialysis. Nat Rev Nephrol [Internet]. 2020;1–3. Available from: http://dx.doi.org/10.1038/s41581-020-0280-y
46. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;0(0).
47. Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy. Kidney Int Reports [Internet]. 2020; Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L2005633870
48. Berhes M, Fabian A, Laszlo I, Vegh T, Molnar C, Fulesdi B, et al. [Organ replacement therapy and life-supporting treatment modalities in critically ill COVID-19 patients]. Orv Hetil. 2020 Apr;161(17):704–9.
49. Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res [Internet]. 2020;190(April):62. Available from: https://doi.org/10.1016/j.thromres.2020.04.014
50. Yan Zhang, M.D. Meng Xiao, M.Sc. Shulan Zhang, M.D. Peng Xia MD, Wei Cao MD, Wei Jiang MD, Huan Chen MD, Xin Ding MD, Hua Zhao, M.D. Hongmin Zhang MD. C or r e sp ondence Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. Nejm. 2020;38(1):1–3.
51. Li X, Wang L, Yan S, Yang F, Xiang L, Zhu J, et al. Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis [Internet]. 2020 Apr;94:128–32. Available from: https://doi.org/10.1016/j.ijid.2020.03.053
52. Karaboyas A, Zee J, Morgenstern H, Nolen JG, Hakim R, Kalantar-zadeh K, et al. Article Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients?: Potential Impact of Changes in Intravenous Iron and Erythropoiesis- Stimulating Agent Dosing. 2015;10(6).
53. Gubensek J, Lolic M, Ponikvar R, Buturovic-ponikvar J. D-dimer levels in maintenance hemodialysis patients?: High prevalence of positive values also in the group without predisposing diseases. 2016;198–203.
54. Brioni E, Leopaldi D, Magnaghi C, Franchetti R, Granellini E, Pegoraro M, et al. [Covid-19 in patients on dialysis: infection prevention and control strategies]. G Ital Nefrol. 2020 Apr;37(2).
55. Alberici F, Del Barba E, Manenti C, Econimo L, Valerio F, Pola A, et al. Managing patients in dialysis and with kidney transplant infected with Covid-19. G Ital Nefrol [Internet]. 2020;37(2). Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L631502106
56. Wang L, Li X, Chen H, Yan S, Li D, Li Y, et al. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. Am J Nephrol [Internet]. 2020;1–6. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L631417498
57. Watnick S, McNamara E. On the Frontline of the COVID-19 Outbreak: Keeping Patients on Long-Term Dialysis Safe. Clin J Am Soc Nephrol. 2020;(Figure 1):2–5.
58. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
59. Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, China. Intensive Care Med [Internet]. 2020;46(2):357–60. Available from: https://doi.org/10.1007/s00134-020-05954-2
60. Asociación Colombiana de Medicina Critica y Cuidado Intensivo (AMCI). Capítulo 3. Ingreso del paciente a UCI. Procedimiento de ingreso y traslado hospitalario. (1). Available from: http://www.amci.org.co/images/consenso/Capitulo_3_Ingreso_del_paciente_a_UCI_Proce_dimiento_de_ingreso_y_traslado_hospitalario.pdf
61. Hospital Brigham Women’s. Ethics. COVID-19 Clinical Guidelines. 2020.
62. OPS. Orientación ética para el uso de recursos limitados en los servicios críticos de salud durante la pandemia de COVID-19. PAHO [Internet]. 2020;21(1):1–9. Available from: https://doi.org/10.1016/j.solener.2019.02.027%0Ahttps://www.golder.com/insights/block-caving-a-viable-alternative/%0A???
63. NICE. COVID-19 rapid guideline: critical care in adults. Natl Inst Heal Care Excell. 2020;(March):2020.
64. Vergano M, Bertolini G, Giannini A, Gristina GR, Livigni S, Mistraletti G, et al. SIAARTI recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances. Minerva Anestesiol. 2020;1–8.
65. Asociación Colombiana de Medicina Critica y Cuidado Intensivo. Capítulo 8. Ética en la atención del paciente COVID-19 La. 2020;1–3.
66. Ministerio de salud y Protección Social. Recomendaciones generales para la toma de decisiones éticas en los servicios de salud durante la pandemia COVID- 19. Minist Salud y Protección Soc - Colomb [Internet]. 2020;1–6. Available from: https://www.minsalud.gov.co/Normatividad_Nuevo/Resolución 1051 de 2016.pdf
67. Sociedad Española de Cuidados Paliativos. Orientaciones sobre el Control sintomático de enfermos graves afectados por la enfermedad Covid 19 y que requieran atención paliativa o se encuentren próximos al final de la vida. 2020;1–8.
68. Sociedad Española de Medicina Intensiva. Recomendaciones éticas para la toma de decisiones en la situación excepcional de crisis por pandemia Covid-19 en las Unidades de Cuidados intensivos. 2020;1–13. Available from: https://www.sedar.es/images/site/BIBLIOGRAFIA_COVID-19/UCI/DOC_OSKD_RECOMENDACIONES_ETICAS_TRIAGE_UCI-CRITICOS.pdf
69. Sorbello M, El-Boghdadly K, Di Giacinto I, Cataldo R, Esposito C, Falcetta S, et al. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia. 2020;(March):1–9.
70. Huh S. How to train health personnel to protect themselves from SARS-CoV-2 (novel coronavirus) infection when caring for a patient or suspected case. J Educ Eval Health Prof. 2020;17:1–6.